TD Asset Management
AURA icon

TD Asset Management’s Aura Biosciences AURA Stock Holding History

TD Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Hold
40,502
– – ﹤0.01% 1212
2025
Q4 		$221K Sell
40,502
-28,528
-41% -$169K ﹤0.01% 1214
2025
Q3 		$427K Hold
69,030
– – ﹤0.01% 1183
2025
Q2 		$432K Hold
69,030
– – ﹤0.01% 1143
2025
Q1 		$405K Hold
69,030
– – ﹤0.01% 1165
2024
Q4 		$567K Buy
69,030
+9,000
+15% +$84.7K ﹤0.01% 1174
2024
Q3 		$542K Sell
60,030
-47,882
-44% -$411K ﹤0.01% 1289
2024
Q2 		$816K Hold
107,912
– – ﹤0.01% 1197
2024
Q1 		$847K Hold
107,912
– – ﹤0.01% 1201
2023
Q4 		$956K Hold
107,912
– – ﹤0.01% 1188
2023
Q3 		$968K Buy
107,912
+53,956
+100% +$580K ﹤0.01% 1148
2023
Q2 		$666K Hold
53,956
– – ﹤0.01% 1210
2023
Q1 		$501K Hold
53,956
– – ﹤0.01% 1265
2022
Q4 		$567K Buy
+53,956
New +$687K ﹤0.01% 1267

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TD Asset Management's AURA Position: Q1 2026 in Review

TD Asset Management held its Aura Biosciences (AURA) position steady in Q1 2026 at 40,502 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

TD Asset Management first reported a position in AURA in Q4 2022 and has held it in 14 quarters since. The position peaked at $968K in Q3 2023. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • TD Asset Management held 40,502 shares of Aura Biosciences worth $271K as of Q1 2026.
  • TD Asset Management left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #1212 holding.
  • TD Asset Management first reported a position in Aura Biosciences in Q4 2022 and has held it in 14 quarters since.
  • TD Asset Management's Aura Biosciences position peaked at $968K in Q3 2023.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.